Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
7,044,428
-
Shares change
-
+583,964
-
Total reported value, excl. options
-
$57,343,099
-
Value change
-
+$2,375,904
-
Put/Call ratio
-
71.15%
-
Number of buys
-
37
-
Number of sells
-
-29
-
Price
-
$8.14
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2025
87 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2025.
AVITA Medical, Inc. - Common Stock (RCEL) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,044,428 shares
of 26,475,256 outstanding shares and own 26.61% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,849,247 shares), VANGUARD GROUP INC (1,433,831 shares), GEODE CAPITAL MANAGEMENT, LLC (619,707 shares), STATE STREET CORP (526,952 shares), Opaleye Management Inc. (440,000 shares), UBS Group AG (344,728 shares), NORTHERN TRUST CORP (269,711 shares), GOLDMAN SACHS GROUP INC (167,039 shares), MARSHALL WACE, LLP (114,092 shares), and AQR CAPITAL MANAGEMENT LLC (98,137 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.